Buy Melinta Therapeutics Stock | MLNT Stock Price & Latest News | Public
MLNT

Melinta Therapeutics

$0.00 (0.00%)Today

    About MLNT

    Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.7
    -1.4
    -2.1
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.85

    Actual EPS
    Q3 2020

    Stats

    Market Cap$1,51M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.60
    1 Year Low$0.06
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app